JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SISENWINE, S. F.
Right arrow Articles by RUELIUS, H. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SISENWINE, S. F.
Right arrow Articles by RUELIUS, H. W.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ISOSORBIDE DINITRATE
Journal of Pharmacology And Experimental Therapeutics, Vol. 176, Issue 2, 296-301, 1971
Copyright © 1971 by American Society for Pharmacology and Experimental Therapeutics


PLASMA CONCENTRATIONS AND URINARY EXCRETION OF ISOSORBIDE DINITRATE AND ITS METABOLITES IN THE DOG

SAMUEL F. SISENWINE 1 and HANS W. RUELIUS 1

1 Research Division, Wyeth Laboratories, Inc., Radnor, Pennsylvania

Plasma concentrations of 14C-isosorbide dinitrate (ISDN) and its metabolites were measured in dogs after administration of either a p.o. or i.v. dose of 14C-ISDN. Negligible levels of radioactivity were observed in erythrocytes. Two minutes after drug administration, ISDN plasma concentrations in p.o. dosed dogs were frac12of those observed in i.v. dosed dogs. ISDN rapidly disappeared from plasma within 1 hour after i.v. administration and within frac12 hour after p.o. administration. The disappearance of drug after the i.v. dose coincided with a rise in mononitrate levels. A similar rise was observed in p.o. dosed dogs, but only after a 15-minute delay. The plasma also contained isosorbide. In urine, no noticeable difference was noted between dosage regimens in the resulting amounts of 5-isosorbide mononitrate, isosorbide and their polar conjugates. Since isosorbide was excreted unchanged in dog urine after a p.o. dose of 14C-isosorbide, it was concluded that the polar conjugate, isosorbide glucuronide, is a transformation product resulting from the denitration of 5-isosorbide mononitrate glucuronide.

Submitted on July 20, 1970
Accepted on October 12, 1970




This article has been cited by other articles:


Home page
ANGIOLOGYHome page
J. Kupersmith
Oral Nitrate Therapy in Coronary Artery Disease
Angiology, June 1, 1977; 28(6): 411 - 415.
[PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1971 by the American Society for Pharmacology and Experimental Therapeutics.